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 Retinal edema is characterized by excessive fluid accu-
mulation in the retina (macula) and is considered to be a seri-
ous complication of ocular inflammation [1-3]. It is one of the
leading causes of visual impairment in patients with uveitis,
with an incidence varying between 24% and 52% depending
on the etiology [4,5]. Inflammatory retinal edema is consid-
ered to occur primarily after the breakdown of the blood-reti-
nal barrier (BRB), which is associated with retinal vascular
leakage, resulting in vasogenic edema [3,6,7]. However, other
reports have suggested that water accumulation within the reti-
nal Müller cells (cytotoxic edema) may also contribute to
macular edema [2,8,9]. The molecular mechanisms and patho-
physiology of retinal edema in endotoxin-induced uveitis (EIU)
have only been partly clarified.
Recent studies of glial potassium channels and water chan-
nels have increased our understanding of the mechanisms of
retinal edema under different pathological conditions. It has
been shown that Müller cells play an important role in K+ spa-
tial buffering in the retina which is known as “K+ siphoning”.
In this model, the Müller cells take up the excess extracellular
K+ ions released during neuronal activity and extrude them
into the blood and the vitreous body [10]. The inwardly recti-
fying potassium channels, particular the subtype of Kir4.1,
have been critically implicated in this process [11]. The Kir4.1
is enriched and highly restricted in the endfoot membranes of
the Müller cells facing the vitreous body and the retinal blood
vessels. It shows rather weaker rectification than that of strong
inwardly rectifying K+ channels such as Kir2.1, allowing ei-
ther inward or outward K+ currents in dependence on the mem-
brane potential and on the concentration of extracellular K+.
The polarized distribution and weak rectification enable Kir4.1
to extrude K+ from the Müller cell endfeet into blood and vit-
reous, which is very important for K+ siphoning [12]. Recent
reports show a decreased expression of Kir4.1 protein in Müller
cells during retinal ischemia reperfusion, uveoretinitis, and
diabetic retinopathy. The Müller cells in the retinas under these
pathological conditions display a downregulation of inward
K+ currents and a hypotonic cell swelling, which may contrib-
ute to the development of cytotoxic macular edema [13-15].
Aquaporin 4 (AQP4) is the most abundant water channel
in the brain and retina. It has been suggested to be critically
involved in the pathogenesis of brain edema under various
injurious circumstances [16,17]. In the retina, AQP4 shows a
similar polarized distribution with Kir4.1 in the endfoot mem-
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Purpose: The inwardly rectifying potassium channel protein Kir4.1 and the water channel protein aquaporin-4 (AQP4)
have been suggested to play essential roles in the potassium and water homeostasis of the retina. In this study, we inves-
tigated the expression of Kir4.1 and AQP4 in the retina during endotoxin-induced uveitis (EIU) in rats.
Methods: EIU was induced in male Wistar rats by intravitreal injection of lipopolysaccharide (LPS). The severity of the
EIU was evaluated by clinical and histopathological examination. The expression of Kir4.1 and AQP4 in the retina was
detected by semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR), Western blotting, and immuno-
histochemical staining.
Results: In the animal model of EIU, the clinical changes correlated well with the histopathological findings. The inflam-
mation peaked at 24 h and resolved by seven day. After an intravitreal LPS injection, the expression of Kir4.1 in the retina
showed a significant decline at both the protein and mRNA levels. In the early stages of EIU, the expression of Kir4.1
mRNA decreased sharply, reaching a minimum at 12 h (31%, p<0.001). It then increased gradually and had partially
recovered 14 days after LPS injection (92%, p>0.05). The expression of Kir4.1 protein decreased significantly, reaching
a minimum at three days after the LPS injection (43%, p<0.001). Thereafter, it increased slightly but was maintained at a
low level until 14 days after LPS injection (64%, p<0.001). In contrast, the expression of AQP4 mRNA remained almost
unchanged after LPS treatment (p>0.05). The expression of AQP4 protein was only slightly reduced at one day (82%,
p>0.05) after LPS injection and then increased gradually and had nearly recovered to the basal level at 14 days after LPS
injection.
Conclusions: EIU differently alters the expression of Kir4.1 and AQP4 in the retina. The differential expression of Kir4.1
and AQP4 during EIU implies a disturbance of water and potassium transport in the retina, which may contribute to the
retinal edema during ocular inflammation.
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branes of Müller cells [18], which facilitates the water flux at
the glio-vascular and glio-vitreal interfaces. The role of AQP4
in retinal edema still remains unclear. It has been shown the
deletion of AQP4 in mice significantly reduces retinal edema
and preserves the retinal function and architecture after reti-
nal ischemia [19]. However, there is only a slight
downregulation of AQP4 expression in the postischemic rat
retina, which does not support the idea that retinal edema af-
ter ischemia is due to changes in AQP4 expression [13].
EIU is an animal model of human ocular inflammation,
and is induced by the administration of lipopolysaccharide
(LPS), a component of the Gram-negative bacterial outer mem-
brane [20]. To investigate the roles of Kir4.1 and AQP4 in the
development of inflammatory retinal edema, we used the ani-
mal model of EIU produced by the intravitreal injection of
LPS to analyze the changes in Kir4.1 and AQP4 expression in
the retina.
METHODS
Animal procedures:  All experiments were performed on male
Wistar rats (6-8 weeks). LPS from Escherichia coli 026:B6
(Sigma, St Louis, MO) was dissolved in sterile phosphate-
buffered saline (PBS) at a concentration of 2 mg/ml. Rats
(n=78) were anesthetized by intraperitoneal injection of mix-
ture of ketamin (80 mg/kg) and xylazine (10 mg/kg). A single
dose of 5 µl of diluted LPS solution was injected intravitreally
into one eye of each rat using a Hamilton microinjector
(Hamilton Co., Reno, NV) under a dissecting microscope. PBS
(5 µl) was administered to the other eye as sham-treated con-
trol. Thirteen rats were left untreated. All animals were treated
in accordance with the ARVO statement for the Use of Ani-
mals in Ophthalmic and Vision Research.
Clinical and histopathological examinations:  Animals
were examined with a slit lamp at 6, 12, 24 h, and 3, 7, and 14
days after LPS or PBS injection. The intensity of clinical ocu-
lar inflammation was scored on a scale of 0-4 using the scor-
ing system devised by Ruiz-Moreno et al. [21] as follows: 0,
no inflammatory reaction; 1, discrete inflammatory reaction;
2, moderate dilation of the iris and conjunctival vessels; 3,
intense iridal hyperemia, with flare in the anterior chamber; 4,
same clinical signs as 3 plus the presence of fibrinoid exuda-
tion in the papillary area, with intense flare in the anterior
chamber.
For histopathological examination, the rats were anesthe-
tized, and killed by transcardial perfusion with heparinized
isotonic saline, followed by 4% paraformaldehyde in PBS.
The eyes were removed and the anterior segments were dis-
sected, postfixed for 2 h in 4% paraformaldehyde, and then
rinsed in saline equilibrated through a sucrose gradient (10-
30% in PBS), and embedded in OCT compound (Tissue-Tek;
Sakura Finetek, Inc., Torrance, CA). Serial frozen sections (10
µm thick) were prepared. Some of the sections were stained
with hematoxylin-eosin, and the others were stained
immunohistochemically. The sections stained with hematoxy-
lin-eosin were observed with an Olympus BX51 light micro-
scope (Olympus Optical Co., Ltd., Tokyo, Japan). Infiltrating
inflammatory cells, including polymorphonuclear neutrophils
and mononuclear cells, were observed in the anterior cham-
ber angle, iris-ciliary body stroma, and retina of the eyes of
EIU rats. EIU was histopathologically scored using Cousins’s
classification [22] on the following scale: 0, between zero and
nine inflammatory cells within the entire microscopic section,
and the absence of other stigmata of inflammation; 1, more
than nine inflammatory cells within the entire microscopic
section but less than 25 inflammatory cells within any given
high-power (40X) field, or at least five inflammatory cell in
the entire cross-section accompanied by anterior chamber pro-
tein and iris hyperemia; 2, more than 25 but less than 60 in-
flammatory cells in a high-power field (40X) with the densest
concentration of infiltrate; 3, 60 or more inflammatory cells
in a single high-power field (40X).
Immunohistochemistry:  For immunohistochemical stud-
ies, the sections were blocked with 10% normal goat serum in
PBS containing 0.2% Triton X-100 for 1 h at room tempera-
ture. The primary antibodies were rabbit anti-Kir4.1 (1:200;
Alomone Laboratories, Jerusalem, Israel), rabbit anti-AQP4
(1:250, Chemicon, Temecula, CA), and mouse anti-glial fibril-
lary acidic protein (GFAP; 1:1000, Transduction Laborato-
ries, Lexington, KY). All were diluted in PBS with 5% goat
serum plus 0.1% Triton X-100. After incubation with the pri-
mary antibodies overnight at 4 °C, the sections were washed
and incubated with Alexa-594-conjugated goat anti-rabbit sec-
ondary antibody or Alexa-488-conjugated goat anti-mouse
antibody (Molecular Probes, Eugene, OR) at 1:500 for 2 h at
room temperature. After the sections had been washed with
PBS, they were mounted and observed with a confocal fluo-
rescence microscope (TCS4D, Leica, Wetzlar, Germany).
Reverse transcriptase polymerase chain reaction:  After
the rats were killed, the total RNA was extracted from freshly
dissected sensory retinas using the TRIzol® Total RNA Isola-
tion System (Invitrogen, Carlsbad, CA, USA). The total RNA
was quantified by ultraviolet spectrophotometry by measur-
ing OD260 and OD280. To eliminate contamination with genomic
DNA, the RNA samples (1 µg) were treated with DNaseI
(deoxyribonuclease I, amplification grade; Invitrogen, Life
Technologies, Inc., Gaithersburg, ML) and then subjected to
reverse transcription using the RevertAid H Minus First Strand
cDNA Synthesis Kit (Fermentas, Life Science, M-Medical Srl,
Cornaredo, Italy). An aliquot (1 µl) of each cDNA sample was
amplified with forward and reverse primers with the follow-
ing sequences. For Kir4.1 mRNA (GenBank accession no.
NM_031602), 5'-GTA GAC ACA GCC TCT GAT AGC C-3'
(836-857) and 5'-AGC AGG TGT GAA CTC GTA GC-3'
(1060-1041), generating a 225-bp amplicon. Reactions were
performed for 30 cycles (94 °C, 45 s; 58 °C, 30 s; 72 °C, 60 s).
For AQP4 mRNA (GenBank accession number U14007), 5'-
GGG TTG GAC CAA TCA TAG GCG CT-3' (701-723) and
5'-GCA GGA AAT CTG AGG CCA GTT CTA GG-3' (1030-
1005), generating a 330-bp amplicon. Reactions were per-
formed for 25 cycles (94 °C, 30 s; 60 °C, 30 s; 72 °C, 60 s).
For β-actin mRNA (GenBank accession number NM_031144),
5'-TAA AGA CCT CTA TGC CAA CAC AGT-3' (951-974)
and 5'-CAC GAT GGA GGG CCG GAC TCA TC-3' (1191-
1168), generating a 240-bp amplicon. Reactions were per-
310formed for 25 cycles (95 °C, 30 s; 60 °C, 30 s; 72 °C, 60 s).
All reactions were performed within the linear range of am-
plification and β-actin was used as the control. The nucleotide
sequences of the PCR products were confirmed by direct se-
quencing analysis. After amplification, the PCR products (5
µl) were run on a 2.0% agarose gel, stained with ethidium
bromide, and photographed. The images were quantitated us-
ing the software ImageJ (NIH).
Western blotting analysis:  At different time points, the
rats were killed with an overdose injection of pentobarbital
and their eyeballs were enucleated. The neural retinas dissected
from the eyecups were weighed and homogenized in ice-cold
lysis buffer containing 50 mM Tris-HCl (pH 7.4), 250 mM
NaCl, and 1% Nonidet P-40, with a protease inhibitor cock-
tail. The protein concentrations of the samples were measured
using the Lowry method [23]. Each protein sample (30 µg)
was separated by 12% sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) for AQP4 and by 7.5% SDS-
PAGE for Kir4.1, and then transferred onto polyvinylidene
difluoride (PVDF) membranes. Immunoblotting was per-
formed using rabbit anti-Kir4.1 (1:1000) or rabbit anti-AQP4
(1:1000) as the primary antibodies and horseradish-peroxi-
dase-conjugated IgG as the secondary antibody. The reaction
products were visualized with ECL Western blotting detec-
tion reagents (Amersham, Buckinghamshire, UK). Images
were captured with a Fuji Film LAS3000 imaging system and
analyzed with MultiGauge software (Fuji Film, Tokyo, Japan).
Statistical analysis:  Quantitative data were expressed as
means±SEM, and were analyzed with one-way analysis of
variance (ANOVA) followed by Dunnett’s test for multiple
comparisons among experimental groups with control groups.
Statistical analysis was performed using the SPSS 10 statisti-
cal software. The results were considered statistically differ-
ent at p<0.05.
RESULTS
Clinical and histopathological scoring of endotoxin-induced
uveitis:  Uveitis developed quickly after the intravitreal LPS
injection. Ocular changes, such as dilation of the iris and con-
junctival vessels, iridal hyperemia, and cells and flare in the
anterior chamber, were observed as early as 6 h after LPS in-
jection. These signs peaked at 24 h, then subsided gradually
during the following period, and had nearly disappeared by
day 7. EIU clinical grades were 1.9 at 6 h, 3.7 at 12 h, 4 at 1
day, 2.5 at 3 day, 0.3 at 7 day, and 0 at 14 day (Table 1). The
eyes of the rats were enucleated at 6, 12, 24 h, and 3, 7, and 14
days after the intravitreal injection of LPS or PBS and stained
with hematoxylin-eosin. Compared with the no-treatment eyes
(Figure 1A,B), some inflammatory cells appeared in the ante-
rior chamber and posterior chamber as early as 6 h after the
LPS injection. At 12 h after the intravitreal injection of LPS,
inflammatory cells appeared in the stroma of the iris-ciliary
body and the retina, as well as the anterior chamber, posterior
chamber, and vitreous body. These changes became more in-
tense and reached a peak 24 h after the injection (Figure 1C,D).
At three day, inflammation became weak and the number of
inflammatory cells had decreased. Seven days after the
intravitreal injection of LPS, only rare inflammatory cells were
detected in the iris-ciliary body and retina (Figure 1E,F). Four-
teen days after the injection, the retina had recovered from
inflammation and no inflammatory cells were seen in the sec-
tions. The histopathological grades were 1.3 at 6 h, 2.8 at 12
h, 3 at 1 day, 2.3 at 3 day, 0.5 at 7 day, and 0 at 14 day (Table
1). In our experiments, the histopathological findings corre-
lated well with the clinical signs. There was no clinical or
histopathological evidence of uveitis in the PBS-treated rats
(Figure 1G,H).
Immunoreactivity of Kir4.1, aquaporin-4, and anti-glial
fibrillary acidic protein in retina:  Immunostaining for Kir4.1,
AQP4, and GFAP was performed at various time points after
LPS or PBS injection. Kir4.1 and AQP4 showed the same
polarized distribution patterns in the retina and retinal blood
vessels. They were enriched in the endfoot membranes facing
the vitreous body and retinal blood vessels (Figure 2A,I). The
Kir4.1 immunoreactivity decreased significantly from one day
after LPS injection, had almost disappeared at 3-7 days after
injection, and had partially recovered by 14 days (Figure 2C-
H). The immunostaining for AQP4 maintained the same pat-
tern during the different stages of EIU and only a slight reduc-
tion in immunoreactivity was observed in the inner plexiform
from 1-7 days after LPS injection (Figure 2K-P). GFAP, a cel-
lular marker for reactive gliosis of the Müller cells, was pre-
dominantly found in astrocytes in the retinas of untreated con-
trol rats. At 7 days and 14 days after intravitreal LPS injec-
tion, the GFAP immunoreactivity in the Müller cells was sig-
nificantly increased (Figure 2Q-X). A mild increase in GFAP
immunoreactivity was also observed in the Müller cells at 7
days (Figure 2R) and 14 days after PBS treatment. No obvi-
ous changes in immunostaining for Kir4.1 (Figure 2B) or AQP4
(Figure 2J) were seen in the retinas of PBS-treated rats.
Kir4.1 and aquaporin-4 mRNA expression in endotoxin-
induced uveitis retinas:  The relative levels of Kir4.1 and AQP4
mRNA expression during EIU were measured by
semiquantitative RT-PCR experiments and subsequently ana-
lyzed after normalization to those of β-actin (Figure 3). The
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TABLE 1. CLINICAL AND HISTOPATHOLOGICAL SCORING OF ENDOTOXIN-
INDUCED UVEITIS
The clinical signs of endotoxin-induced uveitis (EIU) were exam-
ined with a slit lamp and graded on a scale from 0 (normal) to 4
(severe). The hematoxylin-eosin-stained sections were observed un-
der an optical microscope and scored ranging from 0 (normal) to 3
(severe).
311mean values for the untreated control eyes were set at 100%.
In the early stages of EIU, the expression of Kir4.1 mRNA
decreased sharply, reaching a minimum at 12 h (31%,
p<0.001). It then increased gradually and had partially recov-
ered 14 days after LPS injection (92%, p>0.05; Figure 3B). In
contrast, AQP4 mRNA remained unchanged after LPS treat-
ment (Figure 3C). In PBS-treated rats, no obvious changes
were observed in either Kir4.1 or AQP4 mRNA expression at
various time points.
Kir4.1 and aquaporin-4 protein expression in endotoxin-
induced uveitis retinas:  Immunoblotting for Kir4.1 showed a
band at about 200 kDa corresponding to the tetrameric form
of the protein, which is in agreement with the results of prior
study (Figure 4A) [24]. This band decreased significantly,
reaching a minimum at 3 days after the LPS injection (43%,
p<0.001, n=5, mean values for the untreated control eyes were
set at 100%). Thereafter, it increased slightly but was main-
tained at a low level until 14 days after LPS injection (64%,
p<0.001; Figure 4B). Immunoblotting for AQP4 produced two
bands, which represent the two splice variants of AQP4, M1-
AQP4, and M23-AQP4 (Figure 4A) [25]. The magnitude of
AQP4 expression was assessed by combining the absorbance
for both the M1 and M23 forms, as measured by densitom-
etry. The expression of AQP4 was slightly reduced at one day
(82%, p>0.05) after LPS injection. It then increased gradually
and had nearly recovered to the basal level at 14 days (Figure
4C). In PBS-treated rats, no obvious changes were observed
in either Kir4.1 or AQP4 protein expression at various time
points (Figure 4B,C).
DISCUSSION
 Several studies have suggested that there exists a tight cou-
pling between water transport and K+ clearance in the brain.
In the hippocampal slices from α-syntrophin-null mice, the
K+ clearance was significantly delayed, probably resulting from
the mislocalization of AQP4 [26]. It was proposed that a con-
comitant water flux through perivascular AQP4 is required to
sustain the efficient removal of K+ after neuronal activation.
Another piece of evidence for the functional coupling of wa-
ter transport and K+ clearance is that the stimulus-induced
extracellular K+ elevation in sensorimotor cortex causes cell
swelling accompanied by shrinkage of the extracellular space
[27]. In the normal retina, Kir4.1 and AQP4 strictly colocalize
in the endfoot membranes of the Müller cell facing the vitre-
ous body and the retinal blood vessels, suggesting that AQP4-
mediated water transport by Müller cells is coupled to Kir4.1-
mediated K+ siphoning [18]. We have shown here that the ex-
pression of Kir4.1 was significantly reduced, whereas that of
AQP4 was only slightly reduced in retinas after an intravitreal
LPS injection. This differential expression of Kir4.1 and AQP4
in the retina suggests that water transport becomes uncoupled
from K+ siphoning. Since the Kir4.1 channel is predominantly
expressed in membranes through which K+ ions flow out of
Müller cells and enter “extracellular sinks” [12], the
downregulation of Kir4.1 may disturb the efflux of K+ from
the endfeet into blood vessels and vitreous body, followed in
turn by an accumulation of K+ within the Müller cells. Subse-
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Figure 1. Hematoxylin-eosin stained eyes.  A, B: No inflammatory
cells were seen in the anterior chamber (arrowhead), iris-ciliary body
(blank arrow), posterior chamber and retina (double arrowhead) of
untreated control eyes. C, D: Inflammatory cells (arrows) were seen
in the anterior chamber, iris-ciliary body, posterior chamber and retina
one day after lipopolysaccharide (LPS) injection. E, F: Inflamma-
tion had almost subsided and only a few inflammatory cells remained
seven days after LPS injection. G, H: No inflammatory cells were
seen in the sections one day after phosphate-buffered saline treat-
ment. Scale bar represents 20 µm.
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Figure 2. Immunohistochemical
detection of Kir4.1, aquaporin-
4, and anti-glial fibrillary acidic
protein in the retina.  In the nor-
mal eyes, Kir4.1 (A) and
aquaporin-4 (AQP4; I) were en-
riched in the endfoot mem-
branes facing the vitreous body
(arrowheads) and retinal blood
vessels (arrows). Staining for
AQP4 (K-P) maintained the
same pattern during the differ-
ent stages of endotoxin-induced
uveitis (EIU), and only a slight
reduction in immunostaining
was seen in the inner plexiform
at 1-7 day after lipopolysaccha-
ride (LPS) injection. Kir4.1 (C-
H) immunoreactivity decreased
significantly from one day after
LPS injection, had almost dis-
appeared at 3-7 day after injec-
tion, and had partially recovered
by 14 days. Anti-glial fibrillary
acidic protein (GFAP; Q-X) was
predominantly found in astro-
cytes in the retinas of the un-
treated controls. Seven days and
14 days after intravitreal LPS
injection, GFAP (W-X) immu-
noreactivity was significantly
increased in Müller cells. In the
retinas of sham-treated eyes, the
immunostaining for Kir4.1 (A-
H) was unchanged at 3 day af-
ter phosphate-buffered saline
(PBS) treatment (B). AQP4 im-
munoreactivity was unchanged
at one day after PBS treatment
(J). GFAP immunoreactivity
was mildly increased at 7 day
after PBS treatment (R). GCL
indicates ganglion cell layer;
INL indicates inner nuclear
layer; IPL indicates inner plexi-
form layer; ONL indicates outer
nuclear layer; OPL indicates
outer plexiform layer. Scale bar
represents 20 µm.
313quently, the increased intracellular K+ causes an osmotic gra-
dient which drives water from the blood and vitreous into
Müller cells, via the AQP4 in the endfeet which is almost un-
changed, leads to a swelling of the Müller cells (cytotoxic
edema). This hypothesis was also supported by a recent ex-
periment, which showed that Müller cells in retinas from LPS-
treated eyes displayed a hypotonic cell swelling, and a
downregulation of inward K+ currents associated with a de-
creased expression of Kir4.1 protein in retina slices [14].
Moreover, we assumed that the decreased K+ efflux might
parallel a decreased water efflux to blood and vitreous, which
may impair the absorption of vasogenic edema during EIU.
It has been shown that Kir4.1 and AQP4 share a similar
polarized distribution and cocluster in Müller cell membranes
by association with the multiprotein dystrophin-glycoprotein
complex (DGC) [28]. Meanwhile, recent studies also suggested
that the Kir4.1 and AQP4 have different clustering mecha-
nisms and are regulated independently under different patho-
logical conditions. For example, in the α-syntrophin-deficient
mouse, AQP4 is largely mislocalized from the endfoot mem-
branes of the Müller cells, whereas Kir4.1 localization is un-
affected [29]. This finding suggests that α-syntrophin is partly
responsible for anchoring AQP4 but is not involved in an-
choring Kir4.1 in the glial endfoot membranes. The different
redistribution patterns of Kir4.1 and AQP4 in low- and high-
grade human brain tumors also supports the hypothesis of sepa-
rated mechanisms for the clustering of Kir4.1 and AQP4 [30].
Our experiment shows the mislocation of Kir4.1 in the endfoot
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Figure 3. Time course of Kir4.1 and aquaporin-4 mRNA expression in lipopolysaccharide- or phosphate-buffered saline-treated rats.  A: Total
RNA (1 µg) was used for reverse transcriptase polymerase chain reaction (RT-PCR). A 330-bp product for aquaporin-4 (AQP4), a 225-bp
product for Kir4.1, and a 240-bp product for β-actin were separated on a 2.0% agarose gel. B, C: The relative levels of Kir4.1 and AQP4
mRNA expression were quantified. Compared with the control, there was a significant decline in Kir4.1 in lipopolysaccharide (LPS)-treated
animals, whereas there was no change in AQP4 after LPS injection (means±SEM, n=4; asterisk (*) indicates p<0.05, double asterisks (**)
signifies p<0.001 versus control). C indicates control; P indicates phosphate-buffered saline; L represents lipopolysaccharide.
314membranes of Müller cells and an unchanged AQP4 localiza-
tion in EIU. This differential expression pattern implies dif-
ferent regulatory mechanisms for Kir4.1 and AQP4 in ocular
inflammation, which might be due to their different clustering
mechanisms. In addition, the change of Kir4.1 mRNA was
several hours earlier than that of Kir4.1 protein, suggesting
that the decrease in the synthesis and/or degradation of Kir4.1
mRNA proceeded faster than that of Kir4.1 protein. On the
other hand, there was a slight reduction in AQP4 protein level
without a marked change in mRNA level, which might sug-
gest that the downregulation of AQP4 protein was caused by
decreased synthesis of AQP4 protein or accelerated protein
degradation during inflammation.
In vitro experiments have shown that an increase in the
extracellular K+ concentration upregulates LPS-induced ni-
tric oxide (NO) production in astrocytes [31] but inhibits tu-
mor necrosis factor a (TNF-α) and IL-6 production in acti-
vated astrocytes [32]. Moreover, TNF-α causes a marked re-
duction in inwardly rectifying K+ currents in cultured astro-
cytes [33]. These results suggest that there might be a compli-
cated interaction between potassium ions and inflammatory
mediators in the brain. It is known that EIU is accompanied
by a subsequent release of proinflammatory cytokines, pros-
taglandins, NO, and arachidonic acid metabolites in the uvea
and retina [34,35]. In our experiments, the expression of Kir4.1
in the retina decreased significantly in the early stages of EIU
and the reduction persisted for a long time, even when the
inflammation had subsided. Because the changes in Kir4.1
expression and the intensity of ocular inflammation were not
in parallel, the role of Kir4.1 in the inflammatory process of
EIU requires further investigation.
In summary, our results show the differential expression
of Kir4.1 and AQP4 in the retina during EIU in rats, which
implies an uncoupling of AQP4-mediated water transport from
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Figure 4. Time courses of Kir4.1 and aquaporin-4 protein expression in retinas from lipopolysaccharide- or phosphate-buffered saline-treated
rats.  A: Equal amounts of protein (30 µg) were subjected to immunoblotting analysis. A band at about 200 kDa represents Kir4.1 in its
tetrameric form; aquaporin-4 (AQP4) consists of two bands, representing its M1 and M23 forms. B, C: The relative levels of Kir4.1 and AQP4
protein expression were quantified. Compared with that of the control, the expression of Kir4.1 was significantly reduced after LPS injection.
In contrast, there was only a slight, statistically insignificant decline in AQP4 expression from 1 day to 7 day after LPS injection. (means±SEM,
n=5; double asterisks (**) p<0.001 versus control). C indicates control; P indicates phosphate-buffered saline; L indicates lipopolysaccharide.
315Kir4.1-mediated K+ siphoning. This may result in a distur-
bance of potassium and water homeostasis in the retina, which
in turn leads to Müller cells swelling (cytotoxic edema) and
impairment of the absorption of vasogenic edema during EIU.
Moreover, the differential expression of Kir4.1 and AQP4
implies different clustering mechanisms of Kir4.1 and AQP4
in the endfoot membranes of Müller cells. The disturbed po-
tassium homeostasis might be involved in the inflammatory
process in the retina by interacting with the inflammatory
mediators released during EIU. Further investigation of these
mechanisms may lead to a new understanding of EIU, as well
as to novel concepts for the therapeutic management of reti-
nal edema.
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